Health Professional Radio - Podcast

Andy DeLaO, Chief Strategy & Marketing Officer ​a​t GE HealthCare U.S. and Canada, discusses findings from "Reimagining Better Health," GE HealthCare's first-ever international study on the state of healthcare. The study amplifies the united perspectives of patients and clinicians who envision a more human and flexible healthcare experience. #ReimaginingBetterHealth #GEHealthCare...

Dr. Christoph Correll, Professor of Psychiatry at the Zucker School of Medicine discusses common misconceptions about schizophrenia and the challenges that people experience when managing this condition, including adherence to medication and the risk of relapse. Dr. Correll also discusses a recently-approved treatment for adults with schizophrenia called UZEDY ™ (risperidone) extended-release inje...

Dr. Michael Racke, a board-certified neurologist and medical director of neurology at Quest Diagnostics, discusses the advances in blood and other tests for Alzheimer's Disease. He’ll also talk about other practical ways to talk to healthcare providers about the disease, new research that shows how lifestyle changes may reduce risk, and questions people should ask their doctor to assess their...

Shubh Goel, VP, Head of Immunoncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ESMO) 2023 from the MATTERHORN Phase 3 trial data where patients with gastric and gastroesophageal junction cancers are treated with IMFINZI ® (durvalumab) + chemotherapy. The data discusses the improvement seen in patients who were treated with this c...

Dr. Juan Vera, CEO of Marker Therapeutics , a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications discusses the APOLLO trial that is investigating MT-601, a multi-tumor-associated antigen (multiTAA)-specific T cell product targeting six antigens, for the treatment of pa...

Returning guest, Dr. Andrew Cutler, Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and CEO of Florida Clinical Research Center, LLC discusses real-world data from the START study demonstrating favorable efficacy and adherence among people living with TD who used a 4-week titration kit to reach optimal dosing with AUSTEDO ® (deutetrabenazine). Andrew J. Cutler, MD Cli...

David Longo, Co-Founder and CEO of Ordaōs , an AI-driven drug design company, discusses generative AI and how Ordaos is using AI to design novel and customized mini-proteins they refer to as miniPRO ™. They achieve this development through their Odaōs Design Engine which leverages continuous learning loops and proprietary data sets to translate human-defined product criteria into machine-designed...

Aetion Chief Science Officer, Nicolle Gatto, Ph. D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as well as regulatory decisions to inform healthcare’s most critical decisions, advance access to medications, and ultimately improve patient care. #Aetion Nicolle Gatto, Ph. D., M.P.H. Chief Science Officer Nicolle is an epidem...

Dr. David Rosmarin, Ph. D, is the Director of the Spirituality and Mental Health Program at McLean Hospital, associate professor of psychology in the Department of Psychiatry at Harvard Medical School, and founder of Center for Anxiety discusses his new book (Oct 2023) titled "Thriving With Anxiety." He reframes anxiety and explains Anxiety is not a disease; it is a natural human experie...

Jaideep Singh, Co-Founder and CEO of Ambee talks about his passion for the environment, helping people improve their lives, and the groundbreaking environmental data the company has uncovered and how they’re making it actionable with a tech service like Allegra Airways. #Ambee Jaideep Singh is CEO and co-founder at Ambee, a climate tech startup that provides businesses with accurate spatio-tempora...

Dr. Purvi Parikh, a renowned allergist at NYU Langone Health discusses the launch of Allegra's new, first-of-its-kind map app called Airways that guides users to their destinations with real-time cleaner routes (least amount of air pollution and pollen). It essentially identifies a cleaner air commuting route and the best routes to avoid, like the Waze traffic app, but for clean-route commutin...

Lora Sparkman, RN, BSN, MHA, VP, Partner, Clinical Solutions, Patient Safety and Quality at Relias and Nurse.com ambassador, discusses the current maternal mortality crisis and steps healthcare organizations can take to improve the quality of care. #MaternalHealth #MaternalMortality #MaternalMentalHealth Lora Sparkman, MHA, BSN, RN, VP, Partner, Clinical Solutions, Patient Safety and Quality at Re...

Meredith Huetter, a stage lll colorectal cancer survivor, shares her personal story of learning she had CRC and how her treatment journey has gone thus far. #ColorectalCander In March 2020, I started having GI issues, including a change in my bowel habits and blood in my stool. I immediately attributed the issues to stress related to the recent start of the pandemic. I met with my general practiti...

Dr. David Stein, PhD, CEO and Director of Babson Diagnostics   discusses how  Babson is reimagining the blood testing process by only using only a pea-sized amount of blood collected from the finger. Babson’s BetterWay™  Blood Testing eco-system is unique because it brings medically accurate blood testing to the convenience of a retail pharmacy, empowering people to better take charge of their hea...

Norman E. Rosenthal is a psychiatrist and scientist who first described SAD in 1984 and pioneered light therapy as a treatment. Dr. Rosenthal is currently Clinical Professor of Psychiatry at Georgetown University School of Medicine and the author of several books, his most recent being Defeating SAD (Seasonal Affective Disorder): A Guide to Health and Happiness Through All Seasons #SeasonalAffecti...

Chad Worz, PharmD, BCGP, FASCP, Executive Director and Chief Executive Officer of the American Society of Consultant Pharmacists (ASCP) discusses a new flu vaccination campaign from the ASCP and Sanofi that encourages older adults and those with chronic conditions to speak with their healthcare providers or pharmacists about flu vaccine options that may be right for them. #FluVaccine Chad Worz, Ph...

Dr. Steven Quay, Chairman of the Board and CEO of Atossa Therapeutics , a company focused on preventing breast cancer in at-risk women and treating breast cancer in women of all ages, discusses the development of a drug called (z)-endoxifen for breast cancer treatment which is currently undergoing 3 separate phase 2 clinical trials in the US. #BreastCancer #Oncology #ClinicalTrials Steven Quay is...

Sujal Shah, President and CEO of CymaBay Therapeutics , a clinical-stage biopharmaceutical company, discusses the positive topline results from its Phase 3 pivotal RESPONSE study of seladelpar in patients with primary biliary cholangitis (PBC), a rare, chronic inflammatory liver disease. This is the first potential therapy to show promise in significantly improving markers associated with risk of...

Michelle Wulfestieg, Executive Director at Southern California Hospice Foundation and CEO of Heavenly Home discusses how she is fighting the battle of homelessness for the terminally ill and how she is accepting those at Heavenly Home who may lack financial resources and have no other options for end-of-life care. # SCHF #SoCALHospice #socalhospicefoundation With the heart of a servant-leader, Mic...

Arun Krishna, VP, Head of Lung Cancer Franchise, US Oncology Business Unit at AstraZeneca discusses the positive results from the FLAURA2 Phase III trial of TAGRISSO ® (osimertinib) plus chemotherapy and its significance as a new potential treatment option for patients with advanced lung cancer. #LungCancer Arun Krishna, Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit, is...

Returning guest, Dr. Paul Limburg, Chief Medical Officer, Screening at Exact Sciences discusses recent research that revealed countless reasons why 45-year-olds in the U.S. aren’t getting screened for this deadly condition despite recommendations by national screening guidelines. He talks more about how screening can change the course of this deadly disease. #ExactSciences Paul Limburg has served...

Tracy Curley, the CEO of iSpecimen , an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, discusses the iSpecimen platform, the importance of just-in-time biobanking and what’s up next for the industry.  Tracy is an experienced, results-oriented business builder focused on leading iSpecimen’s vision for p...

Dr. Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s pegozafermin in patients with severe hypertriglyceridemia (SHTG) that was published online in "Nature Medicine" (June 24, 2023). To learn more about pegozafermin’s indications in non-alcoholic steatohepatitis (NASH) and severe hypertri...

Dr. Comilla Sasson, MD, PhD, Vice President for Healthcare Business Solutions at the American Heart Association and a practicing Emergency Medicine physician in Denver, Colorado discusses AHA’s newly launched Nation of Lifesavers ™ initiative to double survival rates from sudden cardiac arrest by 2030. The new multi-year initiative will ensure teens and adults can learn about CPR and AED use , sha...

Dr. Erin Crane, MD, MPH, gynecologic oncologist  with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalence of ovarian cancer, risk factors, the importance of biomarker testing, the diagnosis journey, and important questions to ask after diagnosis. #OvarianCancer Erin K. Crane, MD, MPH, is a gynecologic oncologist with the Atrium Health Levine Cance...